SeNostic Overview
- Founded
-
2016

- Status
-
Private
- Employees
-
7

- Latest Deal Type
-
Early Stage VC
- Investors
-
3
SeNostic General Information
Description
Operator of a diagnostics company intended to provide a precise and accurate early differential diagnosis of multiple neurodegenerative disorders. The company provides biochemicals for neuroscience research and develops in Vitro diagnostic tests for neurodegenerative disorders as well as provides a unique way to amplify, and characterize disease-specific protein aggregates present in tissues and body fluids, enabling patients to avail themselves of proper treatment for their disease.
Contact Information
Website
www.senostic.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
- Feodor-Lynen-Straße 21
- 30625 Hannover
- Germany
+49 0511 00000000
SeNostic Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Early Stage VC | 29-May-2019 | Completed | Generating Revenue | |||
2. Seed Round | 25-Jan-2016 | Completed | Generating Revenue | |||
1. Seed Round | Completed | Startup |
SeNostic Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a diagnostics company intended to provide a precise and accurate early differential diagnosis of multiple ne
Biotechnology
Hannover, Germany
7
As of 2022
0000000000 0
SeNostic Competitors (4)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Volastra | Venture Capital-Backed | New York, NY | 00 | 00000 | 00000000000 | 00000 |
000 000000000000 | Venture Capital-Backed | Barcelona, Spain | 00 | 0000 | 00000000000 | 0000 |
000000000 000000 | Venture Capital-Backed | Burlington, MA | 00 | 00000 | 0000000000 0 | 00000 |
0000000 000000 | Venture Capital-Backed | Stockholm, Sweden | 00 | 000.00 | 0000000000 0 | 000.00 |
SeNostic Patents
SeNostic Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4115976-A1 | Reaction vessel | Pending | 05-Jul-2021 | 000000000 | 0 |
EP-3164716-A1 | Process for diagnosis of neurodegenerative diseases | Active | 01-Jul-2014 | 00000000000 | |
EP-3164716-B1 | Process for diagnosis of neurodegenerative diseases | Active | 01-Jul-2014 | 00000000000 | |
ES-2781104-T3 | Procedure for the diagnosis of neurodegenerative diseases | Active | 01-Jul-2014 | 00000000000 | |
US-20200309794-A1 | Shear force generating device for analysis of biopsied mammalian samples | Pending | 01-Jul-2014 | G01N33/6896 |
SeNostic Executive Team (6)
SeNostic Signals
SeNostic Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
NBank Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg | PE/Buyout | Minority | 000 0000 | 000000 0 |